ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 576,47
-0,74%
Dow Jones
40 211,72
0,00%
DAX
18 503,22
-0,52%
Brent Oil
82,90
-1,71%
Bitcoin
63 800,86
-1,62%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
05/04/201216h28PR Newswire (US)Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201214h52PR Newswire (US)Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger w...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201213h10Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201213h00Business WireSpectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/03/201210h14ZacksZacks #1 Rank Additions for Friday - Tale of the TapeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/03/201212h03Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/03/201211h00ZacksAllos Upped to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/03/201222h14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/03/201209h15ZacksAllos Narrows Loss - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/03/201222h00Business WireAllos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/03/201200h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/02/201223h48Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/02/201200h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/02/201214h00Business WireAllos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/201221h33Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/201216h43Edgar (US Regulatory)Schedule 13GNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/02/201216h59Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/02/201218h46ZacksALTH Seeks Review of Folotyn Verdict - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h30Business WireAllos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines AgencyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201214h00Business WireAllos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/01/201213h00ZacksEuropean Setback for Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/01/201213h43Business WireAllos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/01/201218h15ZacksAllos Therapeutics Cut to Neutral - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/01/201214h15ZacksAMAG Q4 Sales Set to Disappoint - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/01/201214h00Business WireAllos Therapeutics Reports 2011 Financial Highlights and Key Business PrioritiesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/12/201114h00Business WireAllos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/12/201116h00ZacksAMAG's Feraheme Gets Canada Nod - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/11/201113h15ZacksAllos Continues to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/11/201114h00ZacksAMAG Hires Financial Advisor - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/11/201110h15ZacksLoss Shrinks at AMAG, CEO Departs - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
EU
PX4
SBF 120
COIN
BTCUSD
Bitcoin
EU
DG
Vinci
EU
ORA
Orange
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
EU
HO
Thales
EU
CAP
Capgemini
NASDAQ
GOOGL
Alphabet
EU
AF
Air FranceKLM
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés